Best Peptides for Injury Recovery & Healing
The peptides most studied for injury recovery and healing are BPC-157 and TB-500, researched for tendon, ligament and soft-tissue repair, along with GHK-Cu for skin and connective tissue and KPV for inflammation. Most evidence comes from animal models with limited human trials.
Recovery peptides are studied for connective-tissue repair and inflammation. BPC-157 (a synthetic gastric peptide) and TB-500 (a thymosin beta-4 fragment) are the two most discussed, researched in animal models for tendon, ligament and muscle healing and frequently studied together. GHK-Cu adds skin and connective-tissue research, and KPV is studied for its anti-inflammatory signaling. Robust human trials are still limited — the evidence is graded honestly below.
⚠ Research & educational use only — not medical adviceMost-studied compounds for injury recovery & healing
Each links to a full research protocol with reconstitution steps, research dose ranges reported in the literature, and an honest evidence grade. Ranked roughly by depth of supporting research.
BPC-157
Tissue repairThe most-studied recovery peptide — animal research shows angiogenesis and collagen support at injury sites; human RCT data is limited.
View protocol →TB-500
Tissue repairA thymosin beta-4 fragment researched for cell migration and soft-tissue repair, often paired with BPC-157.
View protocol →BPC-157 + TB-500
Synergy stackThe classic combined research protocol pairing both repair peptides for complementary mechanisms.
View protocol →GHK-Cu
Connective tissueA copper-binding peptide studied for skin, collagen and wound-healing pathways.
View protocol →Thymosin Beta-4
Repair factorThe parent molecule of TB-500, researched for actin regulation, cell migration and tissue regeneration.
View protocol →KPV
Anti-inflammatoryA tripeptide fragment of alpha-MSH studied for its anti-inflammatory signaling in tissue and gut research.
View protocol →Pentadecapeptide
Gastric peptideA pentadecapeptide closely related to BPC-157, studied for cytoprotective and healing pathways.
View protocol →ARA-290
Tissue protectiveAn EPO-derived peptide researched for tissue protection and neuropathic-inflammation pathways.
View protocol →Sourcing these compounds for research
Researchers studying the molecules above source cGMP-tested material from our official sponsor, LiveWell Peptides. All compounds are sold strictly for laboratory research use.
Source at LiveWell Peptides →Preferred vendor. For research use only. Not for human consumption. Not medical advice.
Plan your research
Free tools to take any compound above from vial to a documented protocol.
Frequently asked questions
- Why are BPC-157 and TB-500 used together in research?
- They act through different mechanisms — BPC-157 is studied mainly for angiogenesis and gut/tendon repair, TB-500 for cell migration and soft-tissue regeneration — so researchers study them together for complementary coverage. See the combined protocol for details.
- Is there human evidence for recovery peptides?
- Most of the strongest data is from animal and in-vitro studies. Human evidence exists but is limited and often anecdotal. Each protocol page grades the evidence specifically.
- Are these peptides legal and FDA-approved?
- Most research peptides discussed here are not FDA-approved for human use and are sold strictly for laboratory research purposes. A few molecules (such as certain GLP-1 receptor agonists) exist in approved prescription forms, but the research-grade material referenced on this site is not the same as a prescription product. Always consult a licensed healthcare provider before making any health decision.
- How strong is the research behind these?
- It varies by compound. Some — like the GLP-1 agonists — have large human clinical trials; others (such as BPC-157 or Epithalon) rest mainly on animal and in-vitro data with limited human studies. Each protocol page on this site grades the evidence so you can see exactly what is well-supported versus preliminary.